T

Twist Bioscience Corp
D

TWST

48.100
USD
0.11
(0.23%)
Market Closed
Volume
28,130
EPS
0
Div Yield
-
P/E
-13
Market Cap
2,855,044,764
Related Instruments
    C
    CDNA
    0.260
    (1.26%)
    20.920 USD
    C
    CRSP
    -0.220
    (-0.54%)
    40.500 USD
    E
    EDIT
    -0.06000
    (-4.55%)
    1.26000 USD
    F
    FATE
    -0.03500
    (-2.07%)
    1.65500 USD
    G
    GH
    -0.650
    (-2.05%)
    31.020 USD
    N
    NTRA
    -0.030
    (-0.02%)
    161.880 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    R
    RPTX
    0.04000
    (3.03%)
    1.36000 USD
    S
    SGMO
    -0.10000
    (-4.02%)
    2.39000 USD
    T
    TCON
    0.00000
    (0.00%)
    1.45000 USD
    More
News

Title: Twist Bioscience Corp

Sector: Healthcare
Industry: Diagnostics & Research
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.